Based on the results of present study, down-regulation of CASP8AP2 which was also associated with leukemic relapse in childhood ALL [11] may be one of the main reasons of chemotherapeutic resistance of low-expression of E2F3a. Here, CASP8AP2 is linked to acute lymphoblastic leukemia.